To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

A Swedish national post-m… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis.

Journal article
Authors Carolina Holmén
Fredrik Piehl
Jan Hillert
Anna Fogdell-Hahn
Malin Lundkvist
Elin Karlberg
Petra Nilsson
Charlotte Dahle
Nils Feltelius
Anders Svenningsson
Jan Lycke
Tomas Olsson
Published in Multiple sclerosis (Houndmills, Basingstoke, England)
Volume 17
Issue 6
Pages 708-19
ISSN 1477-0970
Publication year 2011
Published at Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation
Pages 708-19
Language en
Subject categories Medical and Health Sciences


A post marketing surveillance study was conducted to evaluate safety and efficacy of natalizumab in Swedish multiple sclerosis (MS) patients since its introduction in August 2006 until March 2010.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?